SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-15-002835
Filing Date
2015-05-14
Accepted
2015-05-14 06:00:48
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_051415.htm 10-Q 1224322
2 EXHIBIT 31.1 exh_311.htm EX-31.1 10222
3 EXHIBIT 31.2 exh_312.htm EX-31.2 10314
4 EXHIBIT 32.1 exh_321.htm EX-32.1 6163
5 EXHIBIT 32.2 exh_322.htm EX-32.2 6358
  Complete submission text file 0001171843-15-002835.txt   10722388

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT amph-20150331.xml EX-101.INS 1959774
7 XBRL TAXONOMY EXTENSION SCHEMA amph-20150331.xsd EX-101.SCH 81222
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE amph-20150331_cal.xml EX-101.CAL 49110
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amph-20150331_def.xml EX-101.DEF 359519
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE amph-20150331_lab.xml EX-101.LAB 527559
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amph-20150331_pre.xml EX-101.PRE 361545
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

IRS No.: 330702205 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36509 | Film No.: 15860159
SIC: 2834 Pharmaceutical Preparations